Press "Enter" to skip to content

Galera Therapeutics (GRTX) Says Interim Data from Phase 1/2 Trial of GC4419 with Stereotactic Body Radiation Therapy Showed Improved OS in Patients with LAPC – StreetInsider.com

admin 0

Galera Therapeutics (GRTX) Says Interim Data from Phase 1/2 Trial of GC4419 with Stereotactic Body Radiation Therapy Showed Improved OS in Patients with LAPC  StreetInsider.com
“pancreatic cancer” – Google News

(Visited 1 times, 1 visits today)

Leave a Reply

Your email address will not be published. Required fields are marked *